PubRank

A Brunani

Author PubWeight™ 15.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sympathetic activation in obese normotensive subjects. Hypertension 1995 1.78
2 Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Clin Endocrinol (Oxf) 1990 1.19
3 Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord 1998 1.06
4 Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol 2000 1.00
5 D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 2007 0.99
6 Rationale for hospital-based rehabilitation in obesity with comorbidities. Eur J Phys Rehabil Med 2013 0.83
7 Radial artery compliance in young, obese, normotensive subjects. Hypertension 1995 0.83
8 Creatine kinase and creatine kinase-MB isoenzyme during and after exercise testing in normal and obese young people. Chest 1992 0.82
9 Measuring changes after multidisciplinary rehabilitation of obese individuals. J Endocrinol Invest 2012 0.81
10 Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest 2003 0.81
11 The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistance. Horm Res 2001 0.79
12 [Obesity and Eating Disorders. Indications for the different levels of care. An Italian Expert Consensus Document]. Eat Weight Disord 2010 0.78
13 Effectiveness of in-patient rehabilitation in obesity-related orthopedic conditions. J Endocrinol Invest 2013 0.77
14 Metabolic aspects and sympathetic effects in the obese subject undergoing exercise testing. Minerva Med 1993 0.77
15 Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study. J Endocrinol Invest 2003 0.76
16 Plasma galanin concentrations in obese, normal weight and anorectic women. Int J Obes Relat Metab Disord 1995 0.76
17 Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas. Acta Endocrinol (Copenh) 1991 0.75
18 [Impact of obesity-related disability in different work categories]. G Ital Med Lav Ergon 2013 0.75
19 [Evaluation of the work-related disability in people affected by Ehlers-Danlos syndrome]. G Ital Med Lav Ergon 2013 0.75
20 Sympathetic nerve traffic and baroreflex control of circulation in obese patients: a preliminary report. J Hypertens Suppl 1993 0.75
21 [Applicability of the test SIO on obesity-related disability (TSD-OC) in occupational medicine for the evaluation of work problems linked to overweight-obesity condition]. G Ital Med Lav Ergon 2013 0.75
22 Hyperinsulinemia in the physiologic range is not superior to short-term fasting in suppressing insulin secretion in obese men. Metabolism 2001 0.75
23 Disability in obesity with comorbidities. A perspective from the PRM Societies. Eur J Phys Rehabil Med 2014 0.75
24 Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects. Diabetes Metab 2004 0.75